The shortseller alleged several risks associated with Vykat XR, including high risk of pre-diabetes/diabetes, pulmonary edema ...

Children were reportedly hospitalized after starting treatment. Scorpion Capital suggests Soleno's medication could face ...

Scorpion Capital disclosed a short position in Soleno Therapeutics on Friday, citing issues with the drugmaker's recently approved treatment Vykat XR, sending its shares slumping 15% in premarket ...

Soleno Therapeutics Inc (NASDAQ:SLNO) stock fell 13% Friday morning following a short report from Scorpion Capital that raised serious concerns about the company’s recently approved Prader-Willi ...

Stock futures were mixed on Friday as investors awaited a high-stakes meeting between U.S. and Russian leaders to discuss a ...

Soleno Therapeutics (SLNO) dropped 16% in premarket trading after a new short report from Scorpion Capital. Scorpion Capital ...

How to beat Scorpions in Grounded 2 Pick up on how the Grounded 2 scorpions do battle and you shouldn't have too much trouble taking on one of the park's most dangerous bugs.

Execution risks, such as scaling production and meeting quality standards, persist, compounded by past controversies like a 2021 Scorpion Capital report questioning the company’s viability.

Mortal Kombat 2: How Much Does Scorpion vs. Noob Saibot Factor Into the Sequel? The filmmakers also shed light on Kitana and Jade -- and whether there's a post-credits scene.

The first trailer for the upcoming Scorpions' biopic 'Wind of Change' has been released, with the film hopefully coming out later this year.

Capital One finalizes $35.3B Discover deal, expanding credit card reach after federal OK and lawsuit settlements.

The venom of a common species of Amazonian scorpion may give rise to a potential drug for treating a cancer that is one of the leading causes of death in women.